Korro Bio is trading 5.71% up at $10.55 after recovering from steep losses recorded on September 17 and September 18.
- No new company-specific announcement dated September 22 was identified.
- Korro’s latest listed releases were an inducement grant on September 11 and an August 6 corporate update.
- The broader market is only modestly higher, leaving the immediate catalyst unclear.